Cantor Fitzgerald Reiterates “Hold” Rating for Teladoc, Inc. (TDOC)
Other analysts also recently issued reports about the stock. Canaccord Genuity restated a buy rating and set a $34.00 target price on shares of Teladoc in a report on Wednesday, May 24th. Chardan Capital raised their target price on shares of Teladoc from $30.00 to $41.00 and gave the stock a buy rating in a report on Tuesday, June 20th. Robert W. Baird restated a buy rating and set a $28.00 target price on shares of Teladoc in a report on Tuesday, May 9th. Piper Jaffray Companies restated a buy rating and set a $32.00 target price on shares of Teladoc in a report on Friday, July 14th. Finally, TheStreet downgraded shares of Teladoc from a c- rating to a d rating in a report on Monday, July 3rd. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the stock. Teladoc has an average rating of Buy and an average target price of $35.55.
Shares of Teladoc (NYSE:TDOC) opened at 33.55 on Monday. The company has a 50 day moving average of $32.23 and a 200-day moving average of $28.57. Teladoc has a 12-month low of $14.00 and a 12-month high of $36.90. The company’s market capitalization is $1.90 billion.
Teladoc (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, August 2nd. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.26) by $0.02. The firm had revenue of $44.60 million during the quarter, compared to analyst estimates of $44.39 million. Teladoc had a negative net margin of 47.75% and a negative return on equity of 19.88%. The business’s revenue was up 68.3% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.38) earnings per share. On average, equities analysts anticipate that Teladoc will post ($1.44) EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Cantor Fitzgerald Reiterates “Hold” Rating for Teladoc, Inc. (TDOC)” was first posted by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://www.watchlistnews.com/cantor-fitzgerald-reiterates-hold-rating-for-teladoc-inc-tdoc/1535045.html.
In other news, CEO Jason N. Gorevic sold 13,389 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $32.89, for a total transaction of $440,364.21. Following the completion of the transaction, the chief executive officer now directly owns 831,650 shares of the company’s stock, valued at approximately $27,352,968.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jason N. Gorevic sold 19,991 shares of the firm’s stock in a transaction that occurred on Tuesday, June 6th. The stock was sold at an average price of $32.89, for a total transaction of $657,503.99. Following the transaction, the chief executive officer now directly owns 831,650 shares of the company’s stock, valued at $27,352,968.50. The disclosure for this sale can be found here. Insiders have sold a total of 87,186 shares of company stock valued at $2,761,550 over the last ninety days. Company insiders own 4.47% of the company’s stock.
Several institutional investors have recently modified their holdings of the company. Teachers Advisors LLC boosted its position in shares of Teladoc by 5.3% in the fourth quarter. Teachers Advisors LLC now owns 35,205 shares of the health services provider’s stock valued at $581,000 after buying an additional 1,759 shares in the last quarter. First Mercantile Trust Co. purchased a new position in Teladoc during the first quarter valued at $175,000. Russell Investments Group Ltd. purchased a new position in Teladoc during the first quarter valued at $583,000. Wells Fargo & Company MN boosted its position in Teladoc by 43.8% in the first quarter. Wells Fargo & Company MN now owns 543,568 shares of the health services provider’s stock valued at $13,589,000 after buying an additional 165,435 shares in the last quarter. Finally, Great West Life Assurance Co. Can purchased a new position in Teladoc during the first quarter valued at $105,000.
Teladoc Company Profile
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.